Hepatitis C and renal transplantation.

Area of Science:

• Nephrology
• Hepatology
• Transplantation Immunology

Background:

• Hepatitis C virus (HCV) infection is a significant cause of liver disease post-renal transplantation.
• HCV infection negatively impacts long-term patient and graft survival rates.
• HCV is an independent risk factor for mortality and graft loss, primarily due to cardiovascular issues, liver disease, and infections.

Purpose of the Study:

• To review current insights into hepatitis C virus infection in the context of renal transplantation.
• To highlight the implications of HCV on post-transplant outcomes and management strategies.

Main Methods:

• Review of existing literature on HCV infection and renal transplantation.
• Analysis of outcomes in HCV-positive versus HCV-negative transplant recipients.
• Evaluation of factors contributing to graft failure in HCV-infected patients.

Main Results:

• HCV infection leads to poorer patient and graft survival, increased mortality, and graft failure.
• HCV-related glomerulonephritis and transplant glomerulopathy are key contributors to graft loss.
• Transplantation into HCV RNA-positive recipients using kidneys from anti-HCV antibody-positive donors appears safe long-term.
• Mortality in transplanted HCV-positive patients is lower than in those on the waiting list.

Conclusions:

• Renal transplantation is the preferred treatment for dialysis patients with HCV infection.
• Close outpatient monitoring is essential for early identification and management of HCV-related complications to optimize transplant outcomes.